Vaxcyte Inc (PCVX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vaxcyte Inc   (NASDAQ: PCVX)


Vaxcyte Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vaxcyte Inc's ROI in the second quarter of 2026?
Vaxcyte Inc had a negative return on investment (ROI) of -35.26%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

Within the Healthcare sector 389 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3426 to 3478.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -9.16 % 3.43 % 17.14 % 50.14 % 100.97 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2,867 3,247 2,878 3,081 3,242
Return On Investment (TTM) -35.26 % -30.42 % -24.48 % -20.29 % -16.48 %
PCVX's Overall Ranking # 3478 # 3426 # 3114 # 2435 #
Seq. Investment Change TTM -3.01 % -0.63 % -3.31 % -2.53 % 10.43 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -1,064 -947 -767 -657 -547

PCVX Company Profile >> Back to PCVX Roi Comparisons >> See Annual PCVX Return On Investment



Return On Investment PCVX's Ranking
Within: No.
Industry # 46
Sector # 390
Overall # 3478

Return On Investment Statistics
High Average Low
-16.25 %
-28.7 %
-48.84 %
(Jun 30 2025)   (Sep 30 2022)







Financial Statements
Vaxcyte Inc's II. Quarter Investments $ 2,867 Millions PCVX's Balance sheet
Vaxcyte Inc's II. Quarter Income $ -284 Millions Quarterly PCVX's Income Statement
PCVX's Income by Division See PCVX's Income by Division


PCVX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,686 3,306 1,240 954 284
Y / Y Investment Growth -18.76 % 166.51 % 30.08 % 235.65 % -17.88 %
Net Income in Millions -767 -464 -402 -223 -100
Y / Y Net Income Growth - - - - -
Annual Return On Investment -28.55 % -14.03 % -32.43 % -23.44 % -35.22 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PCVX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PCVX's Competitors
Subscribers only: Roi for Vaxcyte Inc's Suppliers
Subscribers only: Return On Investment for PCVX's Customers

Other Ratios
PCVX's Roa PCVX's Inventory Turnover Ratio PCVX's Growth Rates PCVX's Dividend Statistics
PCVX's Profitability Ratios PCVX's Asset Turnover Ratio PCVX's Dividend Growth
PCVX's Roe PCVX's Valuation Ratios PCVX's Financial Strength Ratios PCVX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T21:31:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.